Vitamin K2
vitaminAlso known as: Menaquinone, MK-7, MK-4, Menaquinone-7, Menaquinone-4
About
Vitamin K2 activates matrix Gla protein (MGP), the most potent natural inhibitor of arterial calcification, directing calcium to bones and away from arteries. The Rotterdam Heart Study (4,807 participants) found the highest vitamin K2 intake was associated with 57% reduction in cardiovascular mortality and 52% reduction in severe aortic calcification.
How It Works
Activates matrix Gla protein (MGP) — the most potent natural inhibitor of arterial calcification — through gamma-carboxylation; directs calcium deposition to bones and away from arteries by activating osteocalcin (bone) and MGP (arteries); the MK-7 form has the longest half-life (72 hours) providing sustained vascular protection; works synergistically with vitamin D.
Evidence For Conditions
| Condition | Grade | Studies | Participants | |
|---|---|---|---|---|
| Arterial Stiffness | B | 5 | 1200 | View → |
Side Effects
- Generally very well-tolerated
- Does not affect blood clotting (INR) at supplemental doses, unlike K1
Drug & Supplement Interactions
- Warfarin (patients on warfarin should consult physician before K2 supplementation)
- Vitamin D (synergistic — D increases MGP production, K2 activates it)
Always inform your healthcare provider about all supplements you take.
Related Ingredients
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.